These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 34916609)

  • 1. Lupeol protects against cardiac hypertrophy via TLR4-PI3K-Akt-NF-κB pathways.
    Li D; Guo YY; Cen XF; Qiu HL; Chen S; Zeng XF; Zeng Q; Xu M; Tang QZ
    Acta Pharmacol Sin; 2022 Aug; 43(8):1989-2002. PubMed ID: 34916609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carnosol prevents cardiac remodeling and ventricular arrhythmias in pressure overload-induced heart failure mice.
    Fang Z; Lu M; Huang R; Wang G; Yushanjiang F; Jiang X; Li J
    Phytother Res; 2024 Jul; 38(7):3763-3781. PubMed ID: 38831669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-(3-7) alleviates isoprenaline-induced cardiac remodeling via attenuating cAMP-PKA and PI3K/Akt signaling pathways.
    Zhang Y; Shang Z; Liu A
    Amino Acids; 2021 Oct; 53(10):1533-1543. PubMed ID: 34494132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pinoresinol diglucoside (PDG) attenuates cardiac hypertrophy via AKT/mTOR/NF-κB signaling in pressure overload-induced rats.
    Chen Y; Pan R; Zhang J; Liang T; Guo J; Sun T; Fu X; Wang L; Zhang L
    J Ethnopharmacol; 2021 May; 272():113920. PubMed ID: 33607200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triad3A attenuates pathological cardiac hypertrophy involving the augmentation of ubiquitination-mediated degradation of TLR4 and TLR9.
    Lu X; He Y; Tang C; Wang X; Que L; Zhu G; Liu L; Ha T; Chen Q; Li C; Xu Y; Li J; Li Y
    Basic Res Cardiol; 2020 Feb; 115(2):19. PubMed ID: 32008145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phillyrin attenuates norepinephrine-induced cardiac hypertrophy and inflammatory response by suppressing p38/ERK1/2 MAPK and AKT/NF-kappaB pathways.
    Tang K; Zhong B; Luo Q; Liu Q; Chen X; Cao D; Li X; Yang S
    Eur J Pharmacol; 2022 Jul; 927():175022. PubMed ID: 35569549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Didymin ameliorates dexamethasone-induced non-alcoholic fatty liver disease by inhibiting TLR4/NF-κB and PI3K/Akt pathways in C57BL/6J mice.
    Feng Z; Pang L; Chen S; Pang X; Huang Y; Qiao Q; Wang Y; Vonglorkham S; Huang Q; Lin X; Wei J
    Int Immunopharmacol; 2020 Nov; 88():107003. PubMed ID: 33182043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumol alleviates cardiac remodeling via the AKT/NF-κB pathway.
    Fang Z; Li S; Yushanjiang F; Feng G; Cui S; Hu S; Jiang X; Liu C
    Int Immunopharmacol; 2023 Sep; 122():110527. PubMed ID: 37392572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacillus Calmette-Guérin and TLR4 agonist prevent cardiovascular hypertrophy and fibrosis by regulating immune microenvironment.
    Liu YY; Cai WF; Yang HZ; Cui B; Chen ZR; Liu HZ; Yan J; Jin W; Yan HM; Xin BM; Yuan B; Hua F; Hu ZW
    J Immunol; 2008 Jun; 180(11):7349-57. PubMed ID: 18490734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tripartite motif 27 promotes cardiac hypertrophy via PTEN/Akt/mTOR signal pathways.
    Chen Y; Liu Z; Hu Z; Feng X; Zuo L
    Bioengineered; 2022 Apr; 13(4):8323-8333. PubMed ID: 35311628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupeol modulates NF-kappaB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice.
    Saleem M; Afaq F; Adhami VM; Mukhtar H
    Oncogene; 2004 Jul; 23(30):5203-14. PubMed ID: 15122342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lycorine inhibits Ang II-induced heart remodeling and inflammation by suppressing the PI3K-AKT/NF-κB pathway.
    Tuo P; Zhao R; Li N; Yan S; Yang G; Wang C; Sun J; Sun H; Wang M
    Phytomedicine; 2024 Jun; 128():155464. PubMed ID: 38484625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin ameliorates pressure overload-induced cardiac hypertrophy by attenuating Atg5-dependent autophagy and activating the Akt/mTOR pathway.
    Xu CN; Kong LH; Ding P; Liu Y; Fan ZG; Gao EH; Yang J; Yang LF
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165848. PubMed ID: 32473999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isorhamnetin protects against cardiac hypertrophy through blocking PI3K-AKT pathway.
    Gao L; Yao R; Liu Y; Wang Z; Huang Z; Du B; Zhang D; Wu L; Xiao L; Zhang Y
    Mol Cell Biochem; 2017 May; 429(1-2):167-177. PubMed ID: 28176246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective Roles of Interferon-γ in Cardiac Hypertrophy Induced by Sustained Pressure Overload.
    Kimura A; Ishida Y; Furuta M; Nosaka M; Kuninaka Y; Taruya A; Mukaida N; Kondo T
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29555642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TIR/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated MyD88-dependent signaling.
    Zhu Y; Li T; Song J; Liu C; Hu Y; Que L; Ha T; Kelley J; Chen Q; Li C; Li Y
    Basic Res Cardiol; 2011 Sep; 106(5):787-99. PubMed ID: 21533832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oleanonic acid ameliorates pressure overload-induced cardiac hypertrophy in rats: The role of PKCζ-NF-κB pathway.
    Gao H; Liu H; Tang T; Huang X; Wang D; Li Y; Huang P; Peng Y
    Mol Cell Endocrinol; 2018 Jul; 470():259-268. PubMed ID: 29138023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamarixetin protects against cardiac hypertrophy via inhibiting NFAT and AKT pathway.
    Fan C; Li Y; Yang H; Cui Y; Wang H; Zhou H; Zhang J; Du B; Zhai Q; Wu D; Chen X; Guo H
    J Mol Histol; 2019 Aug; 50(4):343-354. PubMed ID: 31111288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-217 inhibits apoptosis of atherosclerotic endothelial cells via the TLR4/PI3K/Akt/NF-κB pathway.
    Zhang B; Zhang YF; Li R; Zhao L; Qin SG; Pan LF; Gao YX
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12867-12877. PubMed ID: 33378037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway.
    Wang X; Liu Y; Xiao L; Li L; Zhao X; Yang L; Chen N; Gao L; Zhang J
    Cell Physiol Biochem; 2018; 51(2):827-841. PubMed ID: 30466089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.